Balloon Elution and Late Loss Optimization (BELLO) Study: A Multicentre Randomized Study of the IN.PACT Falcon Paclitaxel Drug-eluting Balloon to Reduce Restenosis in Small Coronary Vessels.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Ischaemia; Unstable angina pectoris
- Focus Biomarker; Therapeutic Use
- Acronyms BELLO
- 14 Aug 2013 Biomarkers information updated
- 02 Nov 2012 Primary endpoint 'Late-loss' has been met.
- 29 May 2012 Planned End Date changed from 1 Sep 2013 to 1 May 2014 as reported by ClinicalTrials.gov record.